RABIVAC-3
RABIVAC-3
Authorised
- ESCHERICHIA COLI
- Pasteurella multocida, Inactivated
- Rabbit haemorrhagic disease virus, Inactivated
Product identification
Medicine name:
RABIVAC-3
Active substance:
- ESCHERICHIA COLI
- Pasteurella multocida, Inactivated
- Rabbit haemorrhagic disease virus, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
ESCHERICHIA COLI0.10/millilitre(s)1.00Dose
-
Pasteurella multocida, Inactivated0.10/millilitre(s)1.00Dose
-
Rabbit haemorrhagic disease virus, Inactivated0.25/millilitre(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AL
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biopharm Infusio Ltd.
Marketing authorisation date:
Manufacturing sites for batch release:
- Sopharma AD
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1457
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 4/06/2026
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 4/06/2026
Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 4/06/2026
